News
Evolent Partnership
Date: 07/07/25
Centene has partnered with Evolent to implement new prior authorization programs. These interventional cardiology, medical oncology, and radiation oncology programs are intended to help providers effectively deliver quality patient care using clinical criteria based on nationally recognized guidelinesto promote evidence-based practices.
Effective September 1, 2025, select interventional cardiology, medical oncology and radiation oncology services will require prior authorization through Evolent prior to being rendered in an outpatient or inpatient* setting (*interventional cardiology only). Read the full notification (PDF).